Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty (Q44723728)

5 December 2017

Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty (English)

1 reference

5 December 2017

Carlo L Romanò

1

1 reference

5 December 2017

Dario Duci

2

1 reference

5 December 2017

Delia Romanò

3

1 reference

5 December 2017

Mario Mazza

4

1 reference

5 December 2017

Enzo Meani

5

1 reference

5 December 2017

1 January 2004

1 reference

5 December 2017

Journal of Arthroplasty

1 reference

5 December 2017

19

1 reference

5 December 2017

1

1 reference

5 December 2017

14-18

1 reference

Clinical Results Using the Mueller-Charnley Total Hip Prosthesis

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Para-Articular Ossifications After Total Hip Replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Indomethacin for prevention of ectopic ossification after hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0883-5403%2803%2900279-1

7 January 2021

10.1016/S0883-5403(03)00279-1

Identifiers

DOI

1 reference

5 December 2017

1 reference